Influence of musculoskeletal pain on workers' ergonomic risk-factor assessments.

This study compares the ergonomic risk-factor assessments of workers with and without musculoskeletal pain. A questionnaire on the musculoskeletal pain experienced in various body regions during the 12 months and seven days preceding the data collection was administered to 473 workers from three industrial sectors. The Ergonomic Workplace Analysis method, developed by the Finnish Institute of Occupational Health (FIOH), was then used by the workers and an ergonomics expert to assess the workstations. The ergonomic quality of the workstations and the need for change were also assessed by the expert and the workers at the workstation, using visual analog scales (VAS). Results show that the workers in this study were exposed to significant musculoskeletal disorder (MSD) risk factors, according to the FIOH assessment and the high percentages of reported pain. The results also show that those who reported pain in the seven days prior to the assessment evaluated their workstations more negatively than subjects who reported no pain, while the expert found no difference between the two groups' exposure to MSD risk factors.

Public health projects for preventing the recurrence of neural tube defects in the United States.

BACKGROUND: The recurrence risk for neural tube defects (NTDs) in subsequent pregnancies is approximately 3%, or 40 times the background risk. Prevention projects target these high-risk women to increase their folic acid consumption during the periconceptional period, a behavior which decreases their recurrence risk by at least 85%. This study surveyed birth defect surveillance programs to assess their NTD recurrence prevention activities and to identify components of intervention projects that might be implemented in states with limited resources. METHODS: In 2005, the National Birth Defects Prevention Network developed and distributed an online survey to primary state birth defects surveillance contacts for the purpose of gathering information on NTD recurrence prevention activities in the United States. RESULTS: Responses came from 37 contacts in 34 states and Puerto Rico. There were 13 active NTD recurrence prevention projects, four past projects, and three planned projects. Fifteen past and present projects recommended that women with a prior NTD-affected birth take 4.0 mg of folic acid daily, and four projects provided folic acid to the women. Reasons given for not having an NTD recurrence prevention project included staffing limitations (53%), lack of funds (47%), lack of priority (18%), and confidentiality/privacy concerns (6%). CONCLUSIONS: Only 15 states and Puerto Rico had or were planning NTD recurrence prevention projects. An NTD recurrence prevention project using minimal resources should consist of timely case ascertainment, educational materials, and mechanisms for disseminating these materials.